VOIDEXRequest access
World News ·

Ivermectin + Mebendazole: Groundbreaking Study Reports 84.4% Clinical Benefit Rate in Cancer Patients

Source: breitbart.com

Ivermectin + Mebendazole: Groundbreaking Study Reports 84.4% Clinical Benefit Rate in Cancer Patients

Open on VOIDEX

Comments

  1. Theo: wow, that sounds really promising for cancer patients. Hope it leads to more effective treatments soon. 🙄

More from World News

You are seeing a public preview. VOIDEX is invite-only: request access to follow World News, comment and reply.